STOCK PURCHASE AGREEMENT AND SHARE EXCHANGE By and among Moneylogix Group, Inc. A Nevada Corporation And Panacea Global, Inc. A Delaware Corporation And The Shareholders of Panacea Global, Inc.
By and
among
Moneylogix
Group, Inc.
A Nevada
Corporation
And
Panacea
Global, Inc.
A
Delaware Corporation
And
The
Shareholders of Panacea Global, Inc.
Effective
as of June 30, 2010
1
SHARE
EXCHANGE AGREEMENT
THIS SHARE EXCHANGE, made and
entered into this 30th day of
June, 2010, by and among Moneylogix Group, Inc., a Nevada corporation with its
principal place of business located at 000 Xxxxxxx Xxxx, Xxxxx 00, Xxxxxxx,
Xxxxxxx X0X 0X0 ("Moneylogix"); Panacea Global, Inc., a Delaware Corporation
with its principal place of business at 00 Xxxxx Xxxxx, Xxxxxxx, Xxxxxxx X0X
0X0 ("Panacea") and all of the shareholders of Panacea (“Panacea
Shareholders”).
Premises
A. This
Agreement provides for the acquisition of Panacea whereby Panacea shall become a
wholly owned subsidiary of Moneylogix and in connection therewith Moneylogix
will issue a total of 74,800,000 shares to the Panacea
Shareholders.
B. The
boards of directors of Moneylogix and Panacea have determined, subject to the
terms and conditions set forth in this Agreement, that the transaction
contemplated hereby is desirable and in the best interests of their
stockholders, respectively. This Agreement is being entered into for
the purpose of setting forth the terms and conditions of the proposed
acquisition.
Agreement
NOW, THEREFORE, on the stated premises
and for and in consideration of the mutual covenants and agreements hereinafter
set forth and the mutual benefits to the parties to be derived here from, it is
hereby agreed as follows:
ARTICLE
I
REPRESENTATIONS,
COVENANTS AND WARRANTIES OF
MONEYLOGIX
GROUP, INC.
As an inducement to and to obtain the
reliance of Panacea, Moneylogix represents and warrants as follows:
Section 1.1 Organization. Moneylogix is a
corporation duly organized, validly existing, and in good standing under the
laws of Nevada and has the corporate power and is duly authorized, qualified,
franchised and licensed under all applicable laws, regulations, ordinances and
orders of public authorities to own all of its properties and assets and to
carry on its business in all material respects as it is now being conducted,
including qualification to do business as a foreign corporation in the
jurisdiction in which the character and location of the assets owned by it or
the nature of the business transacted by it requires
qualification. Included in the Schedules attached hereto (hereinafter
defined) are complete and correct copies of the articles of incorporation,
bylaws and amendments thereto as in effect on the date hereof. The
execution and delivery of this Agreement does not and the consummation of the
transactions contemplated by this Agreement in accordance with the terms hereof
will not violate any provision of Holding's articles of incorporation or
bylaws. Moneylogix has full power, authority and legal right and has
taken all action required by law, its articles of incorporation, its bylaws or
otherwise to authorize the execution and delivery of this
Agreement.
2
Section 1.2 Capitalization. The authorized
capitalization of Moneylogix consists of 300,000,000 Common Shares, $0.001 par
value per share, 10,000,000 Preferred Shares, $0.001 par value per
share. As of the date hereof, Moneylogix has 85,763,586 common
shares issued and outstanding.
All issued and outstanding shares are
legally issued, fully paid and nonassessable and are not issued in violation of
the preemptive or other rights of any person. Moneylogix has no
securities, warrants or options authorized or issued.
Section 1.3 Subsidiaries. Except for
Moneylogix Group, Inc., an Ontario Corporation, Moneylogix has no
subsidiaries.
Section 1.4 Tax Matters: Books and
Records.
|
(a)
|
The
books and records, financial and others, of Moneylogix are in all material
respects complete and correct and have been maintained in accordance with
good business accounting practices;
and
|
|
(b)
|
Moneylogix
has no liabilities with respect to the payment of any country, federal,
state, county, or local taxes (including any deficiencies, interest or
penalties).
|
|
(c)
|
Moneylogix
shall remain responsible for all debts incurred by Moneylogix prior to the
date of closing.
|
Section 1.5 Litigation and Proceedings.
There are no material actions, suits, proceedings or investigations pending or
threatened by or against or affecting Moneylogix or its properties, at law or in
equity, before any court or other governmental agency or instrumentality,
domestic or foreign or before any arbitrator of any kind that would have a
material adverse affect on the business, operations, financial condition or
income of Moneylogix, Moneylogix is not in default with respect to any judgment,
order, writ, injunction, decree, award, rule or regulation of any court,
arbitrator or governmental agency or instrumentality or of any circumstances
which, after reasonable investigation, would result in the discovery of such a
default.
Section 1.6 Material Contract Defaults.
Moneylogix is not in default in any material respect under the terms of
any outstanding contract, agreement, lease or other commitment which is material
to the business, operations, properties, assets or condition of Moneylogix, and
there is no event of default in any material respect under any such contract,
agreement, lease or other commitment in respect of which Moneylogix has not
taken adequate steps to prevent such a default from occurring.
Section 1.7 Information. The information
concerning Moneylogix as set forth in this Agreement and in the attached
Schedules is complete and accurate in all material respects and does not contain
any untrue statement of a material fact or omit to state a material fact
required to make the statements made in light of the circumstances under which
they were made, not misleading.
3
Section 1.8 Title and Related
Matters. Moneylogix
has good and marketable title to and is the sole and exclusive
owner of all of its properties, inventory, interest in properties and assets,
real and personal (collectively, the “Assets”) free and clear of all liens,
pledges, charges or encumbrances. Moneylogix owns free and clear of
any liens, claims, encumbrances, royalty interests or other restrictions or
limitations of any nature whatsoever and all procedures, techniques, marketing
plans, business plans, methods of management or other information utilized in
connection with Moneylogix business. No third party has any
right to, and Moneylogix has not received any notice of infringement of or
conflict with asserted rights of other with respect to any product, technology,
data, trade secrets, know-how, proprietary techniques, trademarks, service
marks, trade names or copyrights which, singly on in the aggregate, if the
subject of an unfavorable decision ruling or finding, would have a materially
adverse affect on the business, operations, financial conditions or income of
Moneylogix or any material portion of its properties, assets or
rights.
Section 1.9 Contracts On the
closing date:
(a)
|
There
are no material contracts, agreements franchises, license agreements, or
other commitments to which Moneylogix is a party or by which it or any of
its properties are bound:
|
(b)
|
Moneylogix
is not a party to any contract, agreement, commitment or instrument or
subject to any charter or other corporate restriction or any judgment,
order, writ, injunction, decree or award materially and adversely affects,
or in the future may (as far as Moneylogix can now foresee) materially and
adversely affect, the business, operations, properties, assets or
conditions of Moneylogix; and
|
(c)
|
Moneylogix
is not a party to any material oral or written: (I) contract for the
employment of any officer or employee; (ii) profit sharing, bonus,
deferred compensation, stock option, severance pay, pension benefit or
retirement plan, agreement or arrangement covered by Title IV of the
Employee Retirement Income Security Act, as amended;
(iii) agreement, contract or indenture relating to the
borrowing of money; (iv) guaranty of any obligation for the borrowing of
money or otherwise, excluding endorsements made for collection and other
guaranties, of obligations, which, in the aggregate exceeds $1,000; (v)
consulting or other contract with an unexpired term of more than one year
or providing for payments in excess of $10,000 in the aggregate; (vi)
collective bargaining agreement; (vii) contract, agreement or other
commitment involving payments by it for more than $10,000 in the
aggregate.
|
Section 1.10 Compliance With Laws and
Regulations. To the best of Moneylogix’s knowledge and belief, Moneylogix
has complied with all applicable statutes and regulations of any federal, state
or other governmental entity or agency thereof, except to the extent that
noncompliance would not materially and adversely affect the business,
operations, properties, assets or condition of Moneylogix or would not result in
Moneylogix incurring material liability.
Section 1.11 Insurance. All of
the insurable properties of Moneylogix are insured for Moneylogix‘s benefit
under valid and enforceable policy or policies containing substantially
equivalent coverage and will be outstanding and in full force at the Closing
Date.
Section 1.12 Approval of Agreement.
The directors of Moneylogix have authorized the execution and delivery of
the Agreement by and have approved the transactions contemplated
hereby.
Section 1.13 Material
Transactions or Affiliations. There are no material contracts or
agreements of arrangement between Moneylogix and any person, who was at the time
of such contract, agreement or arrangement an officer, director or person owning
of record, or known to beneficially own ten percent (10%) or more of the issued
and outstanding Common Shares of Moneylogix and which is to be performed in
whole or in part after the date hereof. Moneylogix has no commitment,
whether written or oral, to lend any funds to, borrow any money from or enter
into material transactions with any such affiliated person.
4
Section 1.14 No Conflict With Other
Instruments. The execution of this Agreement and the consummation of the
transactions contemplated by this Agreement will not result in the breach of any
term or provision of, or constitute an event of default under, any material
indenture, mortgage, deed of trust or other material contract, agreement or
instrument to which Moneylogix is a party or to which any of its properties or
operations are subject.
Section 1.15 Governmental Authorizations.
Moneylogix has all licenses, franchises, permits or other governmental
authorizations legally required to enable it to conduct its business in all
material respects as conducted on the date hereof. Except for compliance with
federal and state securities and corporation laws, as hereinafter provided, no
authorization, approval, consent or order of, or registration, declaration or
filing with, any court or other governmental body is required in connection with
the execution and delivery by Moneylogix of this Agreement and the consummation
of the transactions contemplated hereby.
ARTICLE
II
REPRESENTATIONS,
COVENANTS AND WARRANTIES OF
PANACEA
GLOBAL, INC.
As an inducement to, and to obtain the
reliance of Moneylogix, Panacea represents and warrants as follows:
Section 2.1 Organization. Panacea is a
corporation duly organized, validly existing and in good standing under the laws
of Delaware and has the corporate power and is duly authorized, qualified,
franchised and licensed under all applicable laws, regulations, ordinances and
orders of public authorities to own all of its properties and assets and to
carry on its business in all material respects as it is now being conducted,
including qualification to do business as a foreign entity in the country or
states in which the character and location of the assets owned by it or the
nature of the business transacted by it requires
qualification. Included in the Attached Schedules (as hereinafter
defined) are complete and correct copies of the articles of incorporation,
bylaws and amendments thereto as in effect on the date hereof. The
execution and delivery of this Agreement does not and the consummation of the
transactions contemplated by this Agreement in accordance with the terms hereof
will not, violate any provision of Panacea's certificate of incorporation or
bylaws. Panacea has full power, authority and legal right and has
taken all action required by law, its articles of incorporation, bylaws or
otherwise to authorize the execution and delivery of this
Agreement.
Section 2.2 Capitalization. The authorized
capitalization of Panacea consists of 100,000,000 Common Shares, $0.001 par
value per share and 10,000,000 Preferred Shares, par value $0.001. As
of the date of the merger agreement, 40,000,000 shares of common stock were
outstanding.
All issued and outstanding common
shares have been legally issued, fully paid, are non-assessable and not issued
in violation of the preemptive rights of any other person. Panacea
has no other securities, warrants or options authorized or issued.
Section 2.3 Subsidiaries. Panacea has no
subsidiaries.
5
Section 2.4 Tax Matters; Books &
Records
(a)
|
The
books and records, financial and others, of Panacea are in all material
respects complete and correct and have been maintained in accordance with
good business accounting practices;
and
|
(b)
|
Panacea
has no liabilities with respect to the payment of any country, federal,
state, county, local or other taxes (including any deficiencies, interest
or penalties).
|
(c)
|
Panacea
shall remain responsible for all debts incurred prior to the
closing.
|
Section 2.5 Information. The information
concerning Panacea as set forth in this Agreement and in the attached Schedules
is complete and accurate in all material respects and does not contain any
untrue statement of a material fact or omit to state a material fact required to
make the statements made, in light of the circumstances under which they were
made, not misleading.
Section 2.6 Title and Related Matters.
Panacea has good and marketable title to and is the sole and exclusive owner of
all of its properties, inventory, interests in properties and assets, real and
personal (collectively, the "Assets") free and clear of all liens, pledges,
charges or encumbrances. Except as set forth in the Schedules attached hereto,
Panacea owns free and clear of any liens, claims, encumbrances, royalty
interests or other restrictions or limitations of any nature whatsoever and all
procedures, techniques, marketing plans, business plans, methods of management
or other information utilized in connection with Panacea's business. Except as
set forth in the attached Schedules, no third party has any right to, and
Panacea has not received any notice of infringement of or conflict with asserted
rights of others with respect to any product, technology, data, trade secrets,
know-how, proprietary techniques, trademarks, service marks, trade names or
copyrights which, singly or in the aggregate, if the subject of an unfavorable
decision, ruling or finding, would have a materially adverse affect on the
business, operations, financial conditions or income of Panacea or any material
portion of its properties, assets or rights.
Section 2.7 Litigation and Proceedings.
There are no actions, suits or proceedings pending or threatened by or against
or affecting Panacea, at law or in equity, before any court or other
governmental agency or instrumentality, domestic or foreign or before any
arbitrator of any kind that would have a material adverse effect on the
business, operations, financial condition, income or business prospects of
Panacea. Panacea does not have any knowledge of any default on its
part with respect to any judgment, order, writ, injunction, decree, award, rule
or regulation of any court, arbitrator or governmental agency or
instrumentality.
Section 2.8 Contracts. On the Closing
Date:
(a) There
are no material contracts, agreements, franchises, license agreements, or other
commitments to which Panacea is a party or by which it or any of its properties
are bound;
(b) Panacea
is not a party to any contract, agreement, commitment or instrument or subject
to any charter or other corporate restriction or any judgment, order, writ,
injunction, decree or award which materially and adversely affects, or in the
future may (as far as Panacea can now foresee) materially and adversely affect,
the business, operations, properties, assets or conditions of Panacea;
and
6
(c)Panacea
is not a party to any material oral or written: (i) contract for the
employment of any officer or employee; (ii) profit sharing, bonus,
deferred compensation, stock option, severance pay, pension, benefit or
retirement plan, agreement or arrangement covered by Title IV of the Employee
Retirement Income Security Act, as amended; (iii) agreement, contract or
indenture relating to the borrowing of money; (iv) guaranty of any
obligation for the borrowing of money or otherwise, excluding endorsements made
for collection and other guaranties of obligations, which, in the aggregate
exceeds $1,000; (v) consulting or other contract with an
unexpired term of more than one year or providing for payments in excess of
$10,000 in the aggregate; (vi) collective bargaining
agreement; (vii) contract, agreement, or other commitment
involving payments by it for more than $10,000 in the aggregate.
Section 2.9 No Conflict With Other
Instruments. The execution of this Agreement and the
consummation of the transactions contemplated by this Agreement will not result
in the breach of any term or provision of, or constitute an event of default
under, any material indenture, mortgage, deed of trust or other material
contract, agreement or instrument to which Panacea is a party or to which any of
its properties or operations are subject.
Section 2.10 Material Contract Defaults. To
the best of Panacea's knowledge and belief, it is not in default in any material
respect under the terms of any outstanding contract, agreement, lease or other
commitment which is material to the business, operations, properties, assets or
condition of Panacea, and there is no event of default in any material respect
under any such contract, agreement, lease or other commitment in respect of
which Panacea has not taken adequate steps to prevent such a default from
occurring.
Section 2.11 Governmental
Authorizations. To the best of Panacea’s knowledge,
Panacea has all licenses, franchises, permits and other governmental
authorizations that are legally required to enable it to conduct its business
operations in all material respects as conducted on the date
hereof. Except for compliance with federal and state securities or
corporation laws, no authorization, approval, consent or order of, or
registration, declaration or filing with, any court or other governmental body
is required in connection with the execution and delivery by Panacea of the
transactions contemplated hereby.
Section 2.12 Compliance With Laws and
Regulations. To the best of Panacea's knowledge and belief, Panacea has
complied with all applicable statutes and regulations of any federal, state or
other governmental entity or agency thereof, except to the extent that
noncompliance would not materially and adversely affect the business,
operations, properties, assets or condition of Panacea or would not result in
Panacea's incurring any material liability.
Section 2.13 Insurance. All of
the insurable properties of Panacea are insured for Panacea‘s benefit under
valid and enforceable policy or policies containing substantially equivalent
coverage and will be outstanding and in full force at the Closing
Date.
Section 2.14 Approval of Agreement. The
directors of Panacea have authorized the execution and delivery of the Agreement
and have approved the transactions contemplated hereby.
7
Section 2.15 Material Transactions or
Affiliations. As of the Closing Date, there will exist no material
contract, agreement or arrangement between Panacea and any person who was at the
time of such contract, agreement or arrangement an officer, director or person
owning of record, or known by Panacea to own beneficially, ten percent (10%) or
more of the issued and outstanding Common Shares of Panacea and which is to be
performed in whole or in part after the date hereof except with regard to an
agreement with the Panacea shareholders providing for the distribution of cash
to provide for payment of federal and state taxes on Subchapter S
income. Panacea has no commitment, whether written or oral, to lend
any funds to, borrow any money from or enter into any other material
transactions with, any such affiliated person.
ARTICLE
III
EXCHANGE
PROCEDURE AND OTHER CONSIDERATION
Section 3.1 Share Exchange/Delivery of Panacea
Securities. On the Closing Date, the Panacea Shareholders shall deliver
to Moneylogix (i) certificates or other documents evidencing all of the issued
and outstanding Panacea Common Shares, duly endorsed in blank or with executed
power attached thereto in transferable form. On the Closing Date, all
previously issued and outstanding Common Shares of Panacea shall be transferred
to Moneylogix, so that Panacea shall become a wholly owned subsidiary of
Moneylogix.
Section 3.2 Issuance of Panacea
Common Shares. In exchange for Moneylogix acquiring all of the
Panacea Common Shares tendered pursuant to Section 3.1, Moneylogix shall issue
74,800,000 shares to the Panacea Shareholders in the following
manner:
Xxxxx
Financial Advisory Group-8,500,000 shares
Xxxxxx
Xxxxx-1,000,000 shares
Marciafor
Holdings Inc.-8,000,000 shares
Xxxxxxx
Xxxxxxx-14,800,000 shares
Xxxxxx
Xxxxx Nia-7,000,000 shares
Panacea
Pharmaceuticals, Inc 35,500,000 shares
Such
shares are restricted in accordance with Rule 144 of the 1933 Securities
Act.
Section 3.3 Events Prior to
Closing. Upon execution hereof or as soon thereafter as
practical, management of Moneylogix and Panacea shall execute, acknowledge and
deliver (or shall cause to be executed, acknowledged and delivered) any and all
certificates, opinions, financial statements, schedules, agreements, resolutions
rulings or other instruments required by this Agreement to be so delivered,
together with such other items as may be reasonably requested by the parties
hereto and their respective legal counsel in order to effectuate or evidence the
transactions contemplated hereby, subject only to the conditions to Closing
referenced herein below. In addition, prior to Closing, Panacea shall
provide Moneylogix with updated audited financial statements to be filed with
Moneylogix’s Form 8-K filing with the SEC within three (3) days of
Closing.
Section 3.4 Closing. The closing
("Closing") of the transactions contemplated by this Agreement shall be June 30,
2010.
8
Section 3.6 Termination.
(a)
|
This
Agreement may be terminated by the board of directors or majority interest
of Shareholders of either Moneylogix or Panacea, respectively, at any time
prior to the Closing Date if:
|
(i)
|
there
shall be any action or proceeding before any court or any governmental
body which shall seek to restrain, prohibit or invalidate the transactions
contemplated by this Agreement and which, in the judgment of such board of
directors, made in good faith and based on the advice of its legal
counsel, makes it inadvisable to proceed with the exchange contemplated by
this Agreement; or
|
(ii)
|
any
of the transactions contemplated hereby are disapproved by any regulatory
authority whose approval is required to consummate such
transactions.
|
In the event of termination pursuant to
this paragraph (a) of this Section 3.5, no obligation, right, or liability shall
arise hereunder and each party shall bear all of the expenses incurred by it in
connection with the negotiation, drafting and execution of this Agreement and
the transactions herein contemplated.
(b)
|
This
Agreement may be terminated at any time prior to the Closing Date by
action of the board of directors of Moneylogix if Panacea shall fail to
comply in any material respect with any of its covenants or agreements
contained in this Agreement or if any of the representations or warranties
of Panacea contained herein shall be inaccurate in any material respect,
which noncompliance or inaccuracy is not cured after 20 days written
notice thereof is given to Panacea. If this Agreement is
terminated pursuant to this paragraph (b) of this Section 3.5, this
Agreement shall be of no further force or effect and no obligation, right
or liability shall arise
hereunder.
|
(c)
|
This
Agreement may be terminated at any time prior to the Closing Date by
action of the board of directors of Panacea if Moneylogix shall fail to
comply in any material respect with any of its covenants or agreements
contained in this Agreement or if any of the representations or warranties
of Moneylogix contained herein shall be inaccurate in any material
respect, which noncompliance or inaccuracy is not cured after 20 days
written notice thereof is given to Moneylogix. If this
Agreement is terminated pursuant to this paragraph (d) of this Section
3.5, this Agreement shall be of no further force or effect and no
obligation, right or liability shall arise
hereunder.
|
In the event of termination pursuant to
paragraph (b) and (c) of this Section 3.5, the breaching party shall bear all of
the expenses incurred by the other party in connection with the negotiation,
drafting and execution of this Agreement and the transactions herein
contemplated.
Section 3.7 Directors of Moneylogix After
Acquisition. At Closing, the current directors of Moneylogix
shall resign and Xxxxx Xxxxxx and Xxxxxxx Xxxxxxx shall be appointed as the
members of the Board of Directors of Moneylogix. Each director shall
hold office until his successor shall have been duly elected and shall have
qualified or until his earlier death, resignation or removal.
Section 3.8 Officers of Moneylogix. Upon
the closing, the following persons shall remain the officers of
Moneylogix:
9
NAME
|
OFFICE
|
|
Xxxxx
Xxxxxx
|
President/CEO/CFO
|
|
Xxxxxxx
Xxxxxxx
|
Secretary
|
ARTICLE
IV
SPECIAL
COVENANTS
Section 4.1 Access to Properties and Records.
Prior to closing, Moneylogix and Panacea will each afford to the officers
and authorized representatives of the other full access to the properties, books
and records of each other, in order that each may have full opportunity to make
such reasonable investigation as it shall desire to make of the affairs of the
other and each will furnish the other with such additional financial and
operating data and other information as to the business and properties of each
other, as the other shall from time to time reasonably request.
Section 4.2 Availability of Rule
144. Moneylogix and Panacea shareholders holding "restricted
securities,” as that term is defined in Rule 144 promulgated pursuant to the
Securities Act will remain as “restricted securities”. Moneylogix is
under no obligation to register such shares under the Securities Act, or
otherwise. The stockholders of Moneylogix and Panacea holding restricted
securities of Moneylogix and Panacea as of the date of this Agreement and their
respective heirs, administrators, personal representatives, successors and
assigns, are intended third party beneficiaries of the provisions set forth
herein. The covenants set forth in this Section 4.2 shall survive the
Closing and the consummation of the transactions herein
contemplated.
Section 4.3 Special Covenants and Representations
Regarding the Moneylogix Common Shares to be Issued in the
Exchange. The consummation of this Agreement, including the
issuance of the Moneylogix Common Shares to the Shareholders of Panacea as
contemplated hereby, constitutes the offer and sale of securities under the
Securities Act, and applicable state statutes. Such transaction shall
be consummated in reliance on exemptions from the registration and prospectus
delivery requirements of such statutes which depend, inter alia, upon the
circumstances under which the Panacea Shareholders acquire such
securities.
Section 4.4 Third Party
Consents. Moneylogix and Panacea agree to cooperate with
each other in order to obtain any required third party consents to this
Agreement and the transactions herein contemplated.
Section 4.5 Actions Prior and Subsequent to
Closing.
(i)
|
From
and after the date of this Agreement until the Closing Date, except as
permitted or contemplated by this Agreement, Moneylogix and Panacea will
each use its best efforts to:
|
(ii)
|
maintain
and keep its properties in states of good repair and condition as at
present, except for depreciation due to ordinary wear and tear and damage
due to casualty;
|
(iii)
|
maintain
in full force and effect insurance comparable in amount and in scope of
coverage to that now maintained by
it;
|
(iv)
|
perform
in all material respects all of its obligations under material contracts,
leases and instruments relating to or affecting its assets, properties and
business;
|
10
(b)
From and after the date of this Agreement until
the Closing Date, Moneylogix will not, without
the prior consent of Panacea:
|
(i)
|
Except
as otherwise specifically set forth herein, make any change in its
articles of incorporation or
bylaws;
|
|
(ii)
|
Declare
or pay any dividend on its outstanding Common Shares, except as may
otherwise be required by law, or effect any stock split or otherwise
change its capitalization, except as provided
herein;
|
|
(iii)
|
Enter
into or amend any employment, severance or agreements or arrangements with
any directors or officers;
|
|
(iv)
|
Grant,
confer or award any options, warrants, conversion rights or other rights
not existing on the date hereof to acquire any Common Shares;
or
|
|
(v)
|
Purchase
or redeem any Common Shares.
|
Section
4.6 Indemnification.
(a)
|
Moneylogix
hereby agrees to indemnify Panacea, each of the officers, agents and
directors and current shareholders of Panacea as of the Closing Date
against any loss, liability, claim, damage or expense (including, but not
limited to, any and all expense whatsoever reasonably incurred in
investigating, preparing or defending against any litigation, commenced or
threatened or any claim whatsoever), to which it or they may become
subject to or rising out of or based on any inaccuracy appearing in or
misrepresentation made in this Agreement. The indemnification
provided for in this paragraph shall survive the Closing and consummation
of the transactions contemplated hereby and termination of this Agreement;
and
|
(b)
|
Panacea
hereby agrees to indemnify Moneylogix, each of the officers, agents,
directors and current shareholders of Moneylogix as of the Closing Date
against any loss, liability, claim, damage or expense (including, but not
limited to, any and all expense whatsoever reasonably incurred in
investigating, preparing or defending against any litigation, commenced or
threatened or any claim whatsoever), to which it or they may become
subject arising out of or based on any inaccuracy appearing in or
misrepresentation made in this Agreement. The indemnification provided for
in this paragraph shall survive the Closing and consummation of the
transactions contemplated hereby and termination of this
Agreement.
|
ARTICLE
V
CONDITIONS
PRECEDENT TO OBLIGATIONS OF MONEYLOGIX
The obligations of Moneylogix under
this Agreement are subject to the satisfaction, at or before the Closing Date,
of the following conditions:
Section 5.1 Accuracy of Representations.
The representations and warranties made by Moneylogix in this Agreement were
true when made and shall be true at the Closing Date with the same force and
effect as if such representations and warranties were made at the Closing Date
(except for changes therein permitted by this Agreement), and Moneylogix shall
have performed or compiled with all covenants and conditions required by this
Agreement to be performed or complied with by Moneylogix prior to or at the
Closing. Panacea shall be furnished with a certificate, signed by a duly
authorized officer of Moneylogix and dated the Closing Date, to the foregoing
effect.
11
Section 5.2 Director Approval. The Board
of Directors of Moneylogix shall have approved this Agreement and the
transactions contemplated herein.
Section 5.3 Officer's Certificate. Panacea
shall have been furnished with a certificate dated the Closing Date and signed
by a duly authorized officer of Moneylogix to the effect
that: (a) the representations and warranties of Moneylogix
set forth in the Agreement and in all Exhibits, Schedules and other documents
furnished in connection herewith are in all material respects true and correct
as if made on the Effective Date; (b) Moneylogix has
performed all covenants, satisfied all conditions, and complied with all other
terms and provisions of this Agreement to be performed, satisfied or complied
with by it as of the Effective Date; (c) since such date
and other than as previously disclosed to Panacea, Moneylogix has not entered
into any material transaction other than transactions which are usual
and in the ordinary course if its business; and (d) no
litigation, proceeding, investigation or inquiry is pending or, to the best
knowledge of Moneylogix, threatened, which might result in an action to enjoin
or prevent the consummation of the transactions contemplated by this Agreement
or, to the extent not disclosed in the Moneylogix Schedules, by or against
Moneylogix which might result in any material adverse change in any of the
assets, properties, business or operations of Moneylogix.
Section 5.4 No Material Adverse Change.
Prior to the Closing Date, there shall not have occurred any material adverse
change in the financial condition, business or operations of nor shall any event
have occurred which, with the lapse of time or the giving of notice, may cause
or create any material adverse change in the financial condition, business or
operations of Moneylogix.
Section 5.5 Other Items. Panacea shall
have received such further documents, certificates or instruments relating to
the transactions contemplated hereby as Panacea may reasonably
request.
ARTICLE
VI
CONDITIONS
PRECEDENT TO OBLIGATIONS OF Panacea
The obligations of Panacea under this
Agreement are subject to the satisfaction, at or before the Closing date (unless
otherwise indicated herein), of the following conditions:
Section 6.1 Accuracy of Representations.
The representations and warranties made by Panacea in this Agreement were true
when made and shall be true as of the Closing Date (except for changes therein
permitted by this Agreement) with the same force and effect as if such
representations and warranties were made at and as of the Closing Date, and
Panacea shall have performed and complied with all covenants and conditions
required by this Agreement to be performed or complied with by Panacea prior to
or at the Closing. Moneylogix shall have been furnished with a
certificate, signed by a duly authorized executive officer of Panacea and dated
the Closing Date, to the foregoing effect.
Section 6.2 Director
Approval. The Board of Directors of Panacea shall have
approved this Agreement and the transactions contemplated
herein.
12
Section 6.3 Officer's Certificate.
Moneylogix shall be furnished with a certificate dated the Closing date
and signed by a duly authorized officer of Panacea to the effect
that: (a) the representations and warranties of Panacea set forth in
the Agreement and in all Exhibits, Schedules and other documents furnished in
connection herewith are in all material respects true and correct as if made on
the Effective Date; and (b) Panacea had performed all covenants, satisfied all
conditions, and complied with all other terms and provisions of the Agreement to
be performed, satisfied or complied with by it as of the Effective
Date.
Section 6.4 No Material Adverse Change.
Prior to the Closing Date, there shall not have occurred any material adverse
change in the financial condition, business or operations of nor shall any event
have occurred which, with the lapse of time or the giving of notice, may cause
or create any material adverse change in the financial condition, business or
operations of Panacea.
ARTICLE
VII
MISCELLANEOUS
Section 7.1 Brokers and
Finders. Each party hereto hereby represents and
warrants that it is under no obligation, express or implied, to pay certain
finders in connection with the bringing of the parties together in the
negotiation, execution, or consummation of this Agreement. The parties each
agree to indemnify the other against any claim by any third person for any
commission, brokerage or finder's fee or other payment with respect to this
Agreement or the transactions contemplated hereby based on any alleged agreement
or understanding between the indemnifying party and such third person, whether
express or implied from the actions of the indemnifying party.
Section 7.2 Law, Forum and Jurisdiction.
This Agreement shall be construed and interpreted in accordance with the laws of
the State of Nevada, United States of America.
Section 7.3 Notices. Any
notices or other communications required or permitted hereunder shall be
sufficiently given if personally delivered to it or sent by registered mail or
certified mail, postage prepaid, or by prepaid telegram addressed as
follows:
If
to Moneylogix:
|
000
Xxxxxxx Xxxx
|
Xxxxx
00
Xxxxxxx,
Xxxxxxx X0X 0X0
If
to Panacea:
|
00
Xxxxx Xxxxx
|
Xxxxxxx,
Xxxxxxx X0X 0X0
or such
other addresses as shall be furnished in writing by any party in the manner for
giving notices hereunder, and any such notice or communication shall be deemed
to have been given as of the date so delivered, mailed or
telegraphed.
Section 7.4 Attorneys' Fees. In the event
that any party institutes any action or suit to enforce this Agreement or to
secure relief from any default hereunder or breach hereof, the breaching party
or parties shall reimburse the non-breaching party or parties for all costs,
including reasonable attorneys' fees, incurred in connection therewith and in
enforcing or collecting any judgment rendered therein.
13
Section 7.5 Confidentiality. Each party
hereto agrees with the other party that, unless and until the transactions
contemplated by this Agreement have been consummated, they and their
representatives will hold in strict confidence all data and information obtained
with respect to another party or any subsidiary thereof from any representative,
officer, director or employee, or from any books or records or from personal
inspection, of such other party, and shall not use such data or information or
disclose the same to others, except: (i) to the extent
such data is a matter of public knowledge or is required by law to be published;
and (ii) to the extent that such data or information must be used or
disclosed in order to consummate the transactions contemplated by this
Agreement.
Section 7.6 Schedules; Knowledge. Each
party is presumed to have full knowledge of all information set forth in the
other party's schedules delivered pursuant to this Agreement.
Section 7.7 Third Party Beneficiaries.
This contract is solely between Moneylogix and Panacea and except as
specifically provided, no director, officer, stockholder, employee, agent,
independent contractor or any other person or entity shall be deemed to be a
third party beneficiary of this Agreement.
Section 7.8 Entire Agreement. This
Agreement represents the entire agreement between the parties relating to the
subject matter hereof. This Agreement alone fully and completely
expresses the agreement of the parties relating to the subject matter
hereof. There are no other courses of dealing, understanding,
agreements, representations or warranties, written or oral, except as set forth
herein. This Agreement may not be amended or modified, except by a
written agreement signed by all parties hereto.
Section 7.9 Survival; Termination. The
representations, warranties and covenants of the respective parties shall
survive the Closing Date and the consummation of the transactions herein
contemplated for 18 months.
Section 7.10 Counterparts. This Agreement
may be executed in multiple counterparts, each of which shall be deemed an
original and all of which taken together shall be but a single
instrument.
Section 7.11 Amendment or Waiver. Every
right and remedy provided herein shall be cumulative with every other right and
remedy, whether conferred herein, at law, or in equity, and may be enforced
concurrently herewith, and no waiver by any party of the performance of any
obligation by the other shall be construed as a waiver of the same or any other
default then, theretofore, or thereafter occurring or existing. At
any time prior to the Closing Date, this Agreement may be amended by a writing
signed by all parties hereto, with respect to any of the terms contained herein,
and any term or condition of this Agreement may be waived or the time for
performance hereof may be extended by a writing signed by the party or parties
for whose benefit the provision is intended.
Section 7.12 Expenses. Each party herein
shall bear all of their respective cost s and expenses incurred in connection
with the negotiation of this Agreement and in the consummation of the
transactions provided for herein and the preparation thereof.
Section 7.13 Headings; Context. The
headings of the sections and paragraphs contained in this Agreement are for
convenience of reference only and do not form a part hereof and in no way
modify, interpret or construe the meaning of this Agreement.
Section 7.14 Benefit. This Agreement shall
be binding upon and shall inure only to the benefit of the parties hereto, and
their permitted assigns hereunder. This Agreement shall not be
assigned by any party without the prior written consent of the other
party.
14
Section 7.15 Public Announcements. Except
as may be required by law, neither party shall make any public announcement or
filing with respect to the transactions provided for herein without the prior
consent of the other party hereto.
Section 7.16 Severability. In the event
that any particular provision or provisions of this Agreement or the other
agreements contained herein shall for any reason hereafter be determined to be
unenforceable, or in violation of any law, governmental order or regulation,
such unenforceability or violation shall not affect the remaining provisions of
such agreements, which shall continue in full force and effect and be binding
upon the respective parties hereto.
Section 7.17 Failure of Conditions;
Termination. In the event of any of the conditions specified in this
Agreement shall not be fulfilled on or before the Closing Date, either of the
parties have the right either to proceed or, upon prompt written notice to the
other, to terminate and rescind this Agreement. In such event, the
party that has failed to fulfill the conditions specified in this Agreement will
liable for the other parties legal fees. The election to proceed
shall not affect the right of such electing party reasonably to require the
other party to continue to use its efforts to fulfill the unmet
conditions.
Section 7.18 No Strict Construction. The
language of this Agreement shall be construed as a whole, according to its fair
meaning and intendment, and not strictly for or against either party hereto,
regardless of who drafted or was principally responsible for drafting the
Agreement or terms or conditions hereof.
Section 7.19 Execution Knowing and
Voluntary. In executing this Agreement, the parties severally acknowledge
and represent that each: (a) has fully and carefully read and
considered this Agreement; (b) has been or has had the opportunity to be fully
apprized by its attorneys of the legal effect and meaning of this document and
all terms and conditions hereof; (c) is executing this Agreement voluntarily,
free from any influence, coercion or duress of any kind.
Section 7.20 Amendment. At any
time after the Closing Date, this Agreement may be amended by a writing signed
by both parties, with respect to any of the terms contained herein, and any term
or condition of this Agreement may be waived or the time for performance hereof
may be extended by a writing signed by the party or parties for whose benefit
the provision is intended.
15
IN WITNESS WHEREOF, the
parties hereto have caused this Agreement to be executed, hereunto duly
authorized, and entered into as of the date first above written.
MoneyLogix
Group, Inc.
|
|
By:
|
/s/
Xxxx Cilevitz
|
Name:
Xxxx Cilevitz
|
|
Title:
President
|
|
Panacea
Global, Inc.
|
|
By:
|
/s/
Xxxxxx Xxxxx
|
Name:
Xxxxxx Xxxxx
|
|
Title:
President
|
Panacea
Shareholders:
|
|
Panacea
Pharmaceuticals, Inc.
|
|
By:
|
/s/
Xxxxxxx Xxxxxxxx
|
Name:
Xxxxxxx
Xxxxxxxx
|
|
Title:
President
and Chief Executive
Officer
|
16